Technology transfer of Sabin-IPV to new developing country markets

Biologicals

Volumn 34, Issue 2, 2006, Pages 155-158

  Kreeftenberg, Hans ^a   van der Velden, Tiny ^a   Kersten, Gideon ^a   van der Heuvel, Nico ^a   de Bruijn, Marloes ^a  

^a NETHERLANDS VACCINE INSTITUTE   (Netherlands)

Author keywords

Developing country manufacturers network; IPV production; Micro carrier technology; Sabin derived IPV; Vero cell production

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ARTICLE; DRUG MANUFACTURE; DRUG MARKETING; IMMUNIZATION; NETHERLANDS; PRIORITY JOURNAL; VERO CELL;

ANIMALS; CERCOPITHECUS AETHIOPS; DEVELOPING COUNTRIES; HEALTH POLICY; POLIOVIRUS VACCINE, INACTIVATED; TECHNOLOGY TRANSFER; VERO CELLS;

EID: 33646775678     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2006.02.011     Document Type: Article

References (9)

1. Noort van R.B. The children's vaccine initiative and vaccine supply: the role of the public sector. Vaccine 10 (1992) 909-910
2. van Wezel A.L. Growth of cell-strains and primary cell on microcarriers in homogeneous culture. Nature 216 (1967) 64-65
3. van Wezel A.L., Steenis van G., Hannik C.A., and Cohen H. New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines. Dev Biol Stand 41 (1978) 159-168
4. Salk J., Stoekel P., van Wezel A.L., Lapinleimu K., and van Steenis G. Antigen content of inactivated poliovirus vaccine for use in a one- or two-dose regimen. Ann Clin Res 14 (1982) 204-212
5. Kersten G., Hazendonk T., and Beuvery C. Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains. Vaccine 17 (1999) 2059-2066
6. Steenis van G., van Wezel A.L., and Sekhuis V.M. Potency testing of killed polio vaccine in rats. Dev Biol Stand 47 (1981) 119-128
7. Doi Y., Abe S., Yamamoto H., Horie H., Ohyama H., Satoh K., et al. Progress with inactivated poliovirus vaccines derived from the Sabin strains. Dev Biol 105 (2001) 163-169
8. Global polio eradication initiative. Strategic plan 2004-2008. ISBN 92 4 159117 X.
9. Heymann D.L., Sutter R.W., and Aylward R.B. A global call for new polio vaccines. The end is near, but eradication will not be as simple as once thought. Nature 434 (2005) 699-700